HCA Healthcare Q2 2024 Earnings Report
HCA Healthcare, Inc. (NYSE: HCA) reported its financial and operational results for Q2 2024, ending June 30, 2024. Here are the key highlights: Second Quarter Highlights: Six-Month Summary: Balance Sheet…
CVS Caremark® Sets New Standards for Pharmacy Benefit Management
CVS Caremark®, the top pharmacy benefit manager and a division of CVS Health® (NYSE: CVS), has announced a new commitment to enhance pharmacy benefits for American businesses, unions, and health…
Bristol Myers Squibb Q2 2024 Financial Results
Bristol Myers Squibb (NYSE: BMY) has announced its financial results for Q2 2024. Highlights: Second Quarter Financials: Product Revenue Highlights: Product and Pipeline Updates: Financial Guidance for 2024: Bristol Myers…
Geron Announces NCCN Guidelines Update for RYTELO™ in Lower-Risk MDS
Geron Corporation (Nasdaq: GERN) has announced that the National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include RYTELO™ (imetelstat) as a recommended treatment for symptomatic anemia…
New Study Shows Signatera’s Utility in Merkel Cell Carcinoma
Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA testing, has announced a new study in the Journal of Clinical Oncology showcasing the effectiveness of its personalized molecular residual disease…
Fujirebio Unveils Automated Lumipulse® G GFAP Assay for Research
HU Group Holdings Inc. and its subsidiary, Fujirebio, have announced the launch of the Lumipulse G GFAP assay for use on the fully automated, random-access LUMIPULSE® G immunoassay systems. This…
Insulet Q2 2024 Revenue Preview
Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology with its Omnipod® products, has announced preliminary revenue results for Q2 2024, ending June 30. Full financial results will…
Schrödinger Launches Initiative to Broaden Computational Tools for Predictive Toxicology
Schrödinger, Inc. (Nasdaq: SDGR), renowned for its physics-based computational platform, is launching a new initiative to enhance early-stage drug discovery by predicting toxicology risks. This project aims to improve drug…
Althaia Teams Up with Robbie AI to Prevent Falls in Frail Hospital Patients
The Althaia Foundation is launching an innovative project to prevent falls in frail hospitalized patients using artificial intelligence. In collaboration with Robbie AI, this initiative aims to help healthcare professionals…
Amprion Debuts Next-Gen SAAmplify™ Panels for Neurodegenerative Diagnosis at AAIC 2024
Amprion, a leader in advancing the diagnosis of neurodegenerative disorders through seed amplification testing, is unveiling its new line of cerebrospinal fluid (CSF) biomarker panels under the SAAmplify brand. These…
Merck Gets Positive EU CHMP Opinion for KEYTRUDA® Plus Padcev® in Urothelial Carcinoma
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive…
Glycocalyx Institute Reveals Study Linking Microvascular Health to Fewer Cancer Therapy Side Effects
The Glycocalyx Research Institute is excited to announce groundbreaking results from a recent study exploring the impact of microvascular health—comprising the vast network of tiny capillaries in the body—on acute…